MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517044414 A) filed by Amgen Inc., Thousand Oaks, U.S.A., on May 7, for 'methods for treating obesity.'
Inventor(s) include Strande, Jennifer; Veniant-Ellison, Murielle; and Oberoi, Rajneet.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to methods of treating obesity or type II diabetes using an antagonistic anti-GIPR antibody conjugated to a GLP-1R agonist. In particular, methods for treating obesity or type II diabetes in a patient in need thereof comprising administering to the patient an antagonistic anti-GIPR antibody conjugated to a GLP-1R agonist according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising an antagonistic anti-GIPR antibody conjugated to a GLP-1R agonist for use in the methods are also described."
The patent application was internationally filed on Nov. 07, 2023, under International application No.PCT/US2023/078960.
Disclaimer: Curated by HT Syndication.
